RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,183,891 | +26.4% | 497,490 | +88.8% | 0.01% | +25.0% |
| Q2 2023 | $3,309,648 | -7.3% | 263,507 | +21.5% | 0.00% | 0.0% |
| Q1 2023 | $3,570,976 | +93.4% | 216,817 | +75.5% | 0.00% | +100.0% |
| Q4 2022 | $1,846,016 | -33.2% | 123,562 | +3.5% | 0.00% | -33.3% |
| Q3 2022 | $2,762,000 | +64.9% | 119,362 | +19.4% | 0.00% | +50.0% |
| Q2 2022 | $1,675,000 | -44.0% | 99,997 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $2,993,000 | -1.6% | 99,997 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $3,043,000 | +257.2% | 99,099 | +266.9% | 0.00% | +200.0% |
| Q3 2021 | $852,000 | +18.3% | 27,007 | +21.6% | 0.00% | 0.0% |
| Q2 2021 | $720,000 | -6.2% | 22,207 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $768,000 | +0.8% | 22,207 | +21.1% | 0.00% | 0.0% |
| Q4 2020 | $762,000 | -2.4% | 18,340 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $781,000 | – | 18,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |